Modulation of antitumor immunity with histone deacetylase inhibitors.

about

Dying to Be Noticed: Epigenetic Regulation of Immunogenic Cell Death for Cancer Immunotherapy.

P2860

Q52581847-109E170B-6127-4405-B8D8-09949D4CB358

P2860

Modulation of antitumor immunity with histone deacetylase inhibitors.

Item

http://www.wikidata.org/entity/Q49557954

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Modulation of antitumor immunity with histone deacetylase inhibitors.

@en

Modulation of antitumor immunity with histone deacetylase inhibitors.

@nl

type

Item

label

Modulation of antitumor immunity with histone deacetylase inhibitors.

@en

Modulation of antitumor immunity with histone deacetylase inhibitors.

@nl

prefLabel

Modulation of antitumor immunity with histone deacetylase inhibitors.

@en

Modulation of antitumor immunity with histone deacetylase inhibitors.

@nl

P1476

Modulation of antitumor immunity with histone deacetylase inhibitors

@en

P2093

Andres Forero

http://www.w3.org/2001/XMLSchema#string

Troy D Randall

http://www.w3.org/2001/XMLSchema#string

Tyler R McCaw

http://www.w3.org/2001/XMLSchema#string

P2860

Histone deacetylase inhibition modulates indoleamine 2,3-dioxygenase–dependent DC functions and regulates experimental graft-versus-host disease in mice

Histone deacetylase 1/mSin3A disrupts gamma interferon-induced CIITA function and major histocompatibility complex class II enhanceosome formation

Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes

CD8+ T cell immunity against a tumor/self-antigen is augmented by CD4+ T helper cells and hindered by naturally occurring T regulatory cells.

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

Viral immune evasion due to persistence of activated T cells without effector function

The histone deacetylase inhibitor Trichostatin A modulates CD4+ T cell responses

Post-translational modifications of histones that influence nucleosome dynamics

New and emerging HDAC inhibitors for cancer treatment

Ex-527 inhibits Sirtuins by exploiting their unique NAD+-dependent deacetylation mechanism

P304

1359-1372

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/IMT-2017-0134

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Donald J Buchsbaum

P577

2017-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29185390

http://www.w3.org/2001/XMLSchema#string

P932

6077764

http://www.w3.org/2001/XMLSchema#string

Modulation of antitumor immunity with histone deacetylase inhibitors.

about

P2860

P2860

Modulation of antitumor immunity with histone deacetylase inhibitors.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932